{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T21:19:17Z","timestamp":1786828757229,"version":"build-2736575974"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T00:00:00Z","timestamp":1742083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["43254"],"award-info":[{"award-number":["43254"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007637","name":"German University in Cairo","doi-asserted-by":"publisher","award":["PTC-2020\\u201310-SMH"],"award-info":[{"award-number":["PTC-2020\\u201310-SMH"]}],"id":[{"id":"10.13039\/501100007637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.tranon.2025.102365","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T23:51:56Z","timestamp":1742773916000},"page":"102365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["In-vitro immune-modulation of triple-negative breast cancer through targeting miR-30a-5p\/MALAT1 axis using nano-PDT combinational approach"],"prefix":"10.1016","volume":"55","author":[{"given":"Asmaa","family":"Ramzy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abdel-Halim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Manie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3586-6731","authenticated-orcid":false,"given":"Noha M.","family":"Elemam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6268-7942","authenticated-orcid":false,"given":"Rana A.","family":"Youness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9281-9184","authenticated-orcid":false,"given":"Aya","family":"Sebak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.tranon.2025.102365_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157368","article-title":"Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection","volume":"11","author":"Lehmann","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.tranon.2025.102365_bib0002","doi-asserted-by":"crossref","first-page":"464","DOI":"10.5306\/wjco.v11.i7.464","article-title":"Why natural killer cells in triple negative breast cancer?","volume":"11","author":"Abdel-Latif","year":"2020","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2025.102365_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101961","article-title":"A novel epigenetic strategy to concurrently block immune checkpoints PD-1\/PD-L1 and CD155\/TIGIT in hepatocellular carcinoma","volume":"45","author":"Assal","year":"2024","journal-title":"Transl. Oncol."},{"issue":"15","key":"10.1016\/j.tranon.2025.102365_bib0004","first-page":"13","article-title":"A comprehensive insight and In silico analysis of CircRNAs in hepatocellular carcinoma: a step toward ncRNA-based precision medicine","author":"Youness","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.tranon.2025.102365_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2021.151703","article-title":"Expression of PD-L1 using SP142 CDx in triple negative breast cancer","volume":"51","author":"Al-Jussani","year":"2021","journal-title":"Ann. Diagn. Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.tranon.2025.102365_bib0006","first-page":"31","article-title":"Tumor-infiltrating lymphocytes in triple negative breast cancer: the future of immune targeting","volume":"10","author":"Garcia-Teijido","year":"2016","journal-title":"Clin. Med. Insights Oncol"},{"issue":"4","key":"10.1016\/j.tranon.2025.102365_bib0007","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s11010-022-04378-4","article-title":"MALAT-1\/p53\/miR-155\/miR-146a ceRNA circuit tuned by methoxylated quercitin glycoside alters immunogenic and oncogenic profiles of breast cancer","volume":"477","author":"Abdel-Latif","year":"2022","journal-title":"Mol. Cell. Biochem"},{"issue":"3","key":"10.1016\/j.tranon.2025.102365_bib0008","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2174\/1871520621666210419093652","article-title":"Hindering the synchronization between miR-486-5p and H19 lncRNA by Hesperetin halts breast cancer aggressiveness through tuning ICAM-1","volume":"22","author":"Abdallah","year":"2022","journal-title":"Anticancer Agents. Med. Chem"},{"key":"10.1016\/j.tranon.2025.102365_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CMAR.S316700","article-title":"The characteristics of tumor microenvironment in triple negative breast cancer","volume":"14","author":"Fan","year":"2022","journal-title":"Cancer Manag. Res"},{"issue":"3","key":"10.1016\/j.tranon.2025.102365_bib0010","doi-asserted-by":"crossref","first-page":"769","DOI":"10.32604\/biocell.2022.016636","article-title":"Uncoupling tumor necrosis factor-\u03b1 and interleukin-10 at tumor immune microenvironment of breast cancer through miR-17-5p\/MALAT-1\/H19 circuit","volume":"46","author":"SOLIMAN","year":"2022","journal-title":"BIOCELL"},{"key":"10.1016\/j.tranon.2025.102365_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111436","article-title":"PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines","volume":"138","author":"Lotfinejad","year":"2021","journal-title":"Biomed. Pharmacother"},{"key":"10.1016\/j.tranon.2025.102365_bib0012","doi-asserted-by":"crossref","first-page":"S1435","DOI":"10.1016\/j.annonc.2021.10.153","article-title":"134P Drugless nanoparticles tune-up immune components at triple negative breast cancer tumor microenvironment milieu","volume":"32","author":"Ramzy","year":"2021","journal-title":"Annals. Oncol."},{"issue":"11","key":"10.1016\/j.tranon.2025.102365_bib0013","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/qjmed\/hcq148","article-title":"Inflammation and cancer: macrophage migration inhibitory factor (MIF)\u2013the potential missing link","volume":"103","author":"Conroy","year":"2010","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.tranon.2025.102365_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jir.2014.0026","article-title":"The role of cytokines in breast cancer development and progression","volume":"35","author":"Esquivel-Velazquez","year":"2015","journal-title":"J. Interferon. Cytokine. Res"},{"issue":"10","key":"10.1016\/j.tranon.2025.102365_bib0015","first-page":"11","article-title":"Tumor necrosis factor-alpha (TNFalpha) stimulate triple-negative breast cancer stem cells to promote intratumoral invasion and neovasculogenesis in the liver of a xenograft model","author":"Narasimhan","year":"2022","journal-title":"Biol. (Basel)"},{"issue":"1","key":"10.1016\/j.tranon.2025.102365_bib0016","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/carcin\/bgr257","article-title":"Upregulation of CD9 in ovarian cancer is related to the induction of TNF-\u03b1 gene expression and constitutive NF-\u03bab activation","volume":"33","author":"Hwang","year":"2012","journal-title":"Carcinogenesis"},{"issue":"10","key":"10.1016\/j.tranon.2025.102365_bib0017","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1074\/jbc.M115.702571","article-title":"AP-1 is a key regulator of proinflammatory cytokine TNFalpha-mediated triple-negative breast cancer progression","volume":"291","author":"Qiao","year":"2016","journal-title":"J. Biol. Chem"},{"issue":"21","key":"10.1016\/j.tranon.2025.102365_bib0018","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.3390\/ijms21218363","article-title":"Lactic acid and an acidic tumor microenvironment suppress anticancer immunity","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci"},{"issue":"7203","key":"10.1016\/j.tranon.2025.102365_bib0019","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.tranon.2025.102365_bib0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cellimm.2010.09.010","article-title":"Human breast tumor cells express IL-10 and IL-12p40 transcripts and proteins, but do not produce IL-12p70","volume":"266","author":"Heckel","year":"2011","journal-title":"Cell Immunol."},{"issue":"5","key":"10.1016\/j.tranon.2025.102365_bib0021","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.21873\/anticanres.15020","article-title":"Contribution of interleukin-10 genotype to triple negative breast cancer risk","volume":"41","author":"Chen","year":"2021","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tranon.2025.102365_bib0022","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1017\/erm.2023.26","article-title":"Pharmacogenomic and epigenomic approaches to untangle the enigma of IL-10 blockade in oncology","volume":"26","author":"Elemam","year":"2024","journal-title":"Expert Rev. Mol. Med"},{"issue":"9","key":"10.1016\/j.tranon.2025.102365_bib0023","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/jcp.31076","article-title":"Decoding hepatocarcinogenesis from a noncoding RNAs perspective","volume":"238","author":"El-Aziz","year":"2023","journal-title":"J. Cell Physiol"},{"issue":"22","key":"10.1016\/j.tranon.2025.102365_bib0024","first-page":"24","article-title":"Emerging role of circular RNAs in Hepatocellular carcinoma immunotherapy","author":"Abaza","year":"2023","journal-title":"Int. J. Mol. Sci"},{"issue":"7414","key":"10.1016\/j.tranon.2025.102365_bib0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature11233","article-title":"Landscape of transcription in human cells","volume":"489","author":"Djebali","year":"2012","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.tranon.2025.102365_bib0026","doi-asserted-by":"crossref","first-page":"e21063","DOI":"10.1016\/j.heliyon.2023.e21063","article-title":"Dual targeting of H(2)S synthesizing enzymes; cystathionine \u03b2-synthase and cystathionine \u03b3-lyase by miR-939-5p effectively curbs triple negative breast cancer","volume":"9","author":"Nafea","year":"2023","journal-title":"Heliyon"},{"issue":"12","key":"10.1016\/j.tranon.2025.102365_bib0027","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1111\/jcmm.12920","article-title":"The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer","volume":"20","author":"Wang","year":"2016","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.tranon.2025.102365_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154579","article-title":"Let-7a\/cMyc\/CCAT1\/miR-17-5p circuit re-sensitizes atezolizumab resistance in triple negative breast cancer through modulating PD-L1","volume":"248","author":"Selem","year":"2023","journal-title":"Pathol. Res. Pract"},{"issue":"5","key":"10.1016\/j.tranon.2025.102365_bib0029","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1007\/s13277-015-4456-1","article-title":"Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH\/PTEN\/AKT pathway","volume":"37","author":"Li","year":"2016","journal-title":"Tumour. Biol"},{"issue":"3","key":"10.1016\/j.tranon.2025.102365_bib0030","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3892\/ijo.2016.3319","article-title":"Downregulation of \u03b23 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk\/Ets\u20111 network in triple-negative breast cancer corrigendum in\/10.3892\/ijo. 2021.5169","volume":"48","author":"Li","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.tranon.2025.102365_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101653","article-title":"MALAT-1: immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer","volume":"31","author":"Mekky","year":"2023","journal-title":"Transl. Oncol"},{"issue":"4","key":"10.1016\/j.tranon.2025.102365_bib0032","first-page":"418","article-title":"Clinical significance of long non-coding RNA MALAT1 expression in tissue and serum of breast cancer","volume":"46","author":"Miao","year":"2016","journal-title":"Ann. Clin. Lab. Sci"},{"issue":"6","key":"10.1016\/j.tranon.2025.102365_bib0033","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.1007\/s13277-015-4605-6","article-title":"Reciprocal regulation of hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development","volume":"37","author":"Jin","year":"2016","journal-title":"Tumor. Biol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102365_bib0034","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10911-022-09511-z","article-title":"Decoding insulin-like growth factor signaling pathway from a non-coding RNAs perspective: a step towards precision oncology in breast cancer","volume":"27","author":"ZeinElAbdeen","year":"2022","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"1","key":"10.1016\/j.tranon.2025.102365_bib0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000493962","article-title":"Long non-coding MALAT1 functions as a competing endogenous RNA to regulate vimentin expression by sponging miR-30a-5p in hepatocellular carcinoma","volume":"50","author":"Pan","year":"2018","journal-title":"Cell Physiol. Biochem"},{"issue":"2","key":"10.1016\/j.tranon.2025.102365_bib0036","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.18632\/oncotarget.23370","article-title":"Roles of MALAT1 in development and migration of triple negative and her-2 positive breast cancer","volume":"9","author":"Xiping","year":"2018","journal-title":"Oncotarget"},{"issue":"21","key":"10.1016\/j.tranon.2025.102365_bib0037","first-page":"14","article-title":"Molecular engines, therapeutic targets, and challenges in pediatric brain tumors: a special emphasis on hydrogen sulfide and RNA-based nano-delivery","author":"Fahmy","year":"2022","journal-title":"Cancer. (Basel)"},{"issue":"47","key":"10.1016\/j.tranon.2025.102365_bib0038","doi-asserted-by":"crossref","first-page":"44424","DOI":"10.1021\/acsomega.3c04134","article-title":"A snapshot of photoresponsive liposomes in cancer chemotherapy and immunotherapy: opportunities and challenges","volume":"8","author":"Youness","year":"2023","journal-title":"ACS. Omega"},{"issue":"7","key":"10.1016\/j.tranon.2025.102365_bib0039","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1039\/D3RA08042K","article-title":"Emerging tendencies for the nano-delivery of gambogic acid: a promising approach in oncotherapy","volume":"14","author":"Fahmy","year":"2024","journal-title":"RSC Adv"},{"key":"10.1016\/j.tranon.2025.102365_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2023.103792","article-title":"Phytochemical-derived tumor-associated macrophage remodeling strategy using Phoenix dactylifera L. boosted photodynamic therapy in melanoma via H19\/iNOS\/PD-L1 axis","volume":"44","author":"Soliman","year":"2023","journal-title":"Photodiagnosis. Photodyn. Ther"},{"key":"10.1016\/j.tranon.2025.102365_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121775","article-title":"Drug self-delivery nanorods enhance photodynamic therapy of triple-negative breast cancer by inhibiting oxidative phosphorylation","volume":"621","author":"Gao","year":"2022","journal-title":"Int. J. Pharm"},{"issue":"3","key":"10.1016\/j.tranon.2025.102365_bib0042","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030626","article-title":"Selective photo-assisted eradication of triple-negative breast cancer cells through aptamer decoration of doped conjugated polymer nanoparticles","volume":"14","author":"Ibarra","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tranon.2025.102365_bib0043","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.biopha.2016.07.058","article-title":"The potential of photodynamic therapy (PDT)-experimental investigations and clinical use","volume":"83","author":"Oniszczuk","year":"2016","journal-title":"Biomed. Pharmacother"},{"issue":"5","key":"10.1016\/j.tranon.2025.102365_bib0044","first-page":"1085","article-title":"Efficient preparation of highly pure chlorin e6 and its photodynamic anti-cancer activity in a rat tumor model","volume":"22","author":"Moon","year":"2009","journal-title":"Oncol. Rep"},{"issue":"1","key":"10.1016\/j.tranon.2025.102365_bib0045","doi-asserted-by":"crossref","first-page":"FSO225","DOI":"10.4155\/fsoa-2017-0064","article-title":"Chitosan immunomodulatory properties: perspectives on the impact of structural properties and dosage","volume":"4","author":"Fong","year":"2018","journal-title":"Fut. Sci. OA"},{"issue":"16","key":"10.1016\/j.tranon.2025.102365_bib0046","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.1021\/acs.macromol.2c00854","article-title":"Immunostimulatory polymers as adjuvants, immunotherapies, and delivery systems","volume":"55","author":"Weiss","year":"2022","journal-title":"Macromolecules"},{"key":"10.1016\/j.tranon.2025.102365_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.888740","article-title":"Recent advances in Chitosan and its derivatives in cancer treatment","volume":"13","author":"Ding","year":"2022","journal-title":"Front. Pharmacol"},{"key":"10.1016\/j.tranon.2025.102365_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2021.108357","article-title":"Plausible role of chitosan in drug and gene delivery against resistant breast cancer cells","volume":"506","author":"Nandgude","year":"2021","journal-title":"Carbohydr. Res"},{"issue":"6","key":"10.1016\/j.tranon.2025.102365_bib0049","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.apsb.2019.08.003","article-title":"Recent progress in drug delivery","volume":"9","author":"Li","year":"2019","journal-title":"Acta. Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.tranon.2025.102365_bib0050","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s13577-020-00380-4","article-title":"Clinical relevance of tumor microenvironment: immune cells, vessels, and mouse models","volume":"33","author":"Katsuta","year":"2020","journal-title":"Hum. Cell"},{"issue":"3","key":"10.1016\/j.tranon.2025.102365_bib0051","doi-asserted-by":"crossref","DOI":"10.3390\/md20030156","article-title":"Enhancing stability and mucoadhesive properties of chitosan nanoparticles by surface modification with sodium alginate and polyethylene glycol for potential oral Mucosa vaccine delivery","volume":"20","author":"Amin","year":"2022","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.tranon.2025.102365_bib0052","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s10311-019-00904-x","article-title":"Applications of chitosan in food, pharmaceuticals, medicine, cosmetics, agriculture, textiles, pulp and paper, biotechnology, and environmental chemistry","volume":"17","author":"Morin-Crini","year":"2019","journal-title":"Environ. Chem. Lett"},{"key":"10.1016\/j.tranon.2025.102365_bib0053","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.carbpol.2004.06.033","article-title":"Physicochemical properties and blood compatibility of acylated chitosan nanoparticles","volume":"58","author":"Lee","year":"2004","journal-title":"Carbohydr. Polym"},{"key":"10.1016\/j.tranon.2025.102365_bib0054","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-3-030-42667-5_3","article-title":"Bioactive lipids in age-related disorders","volume":"1260","author":"Das","year":"2020","journal-title":"Adv. Exp. Med. Biol"},{"issue":"1","key":"10.1016\/j.tranon.2025.102365_bib0055","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/aca85d","article-title":"Drugless nanoparticles tune-up an array of intertwined pathways contributing to immune checkpoint signaling and metabolic reprogramming in triple-negative breast cancer","volume":"18","author":"Ramzy","year":"2022","journal-title":"Biomed. Mater"},{"key":"10.1016\/j.tranon.2025.102365_bib0056","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.foodchem.2017.05.134","article-title":"Structural characterization, formation mechanism and stability of curcumin in zein-lecithin composite nanoparticles fabricated by antisolvent co-precipitation","volume":"237","author":"Dai","year":"2017","journal-title":"Food Chem"},{"key":"10.1016\/j.tranon.2025.102365_bib0057","article-title":"Folate targeted lipid chitosan hybrid nanoparticles for enhanced anti-tumor efficacy","volume":"28","author":"Khan","year":"2020","journal-title":"Nanomedicine"},{"issue":"8","key":"10.1016\/j.tranon.2025.102365_bib0058","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.drudis.2015.05.001","article-title":"Drug repositioning and repurposing: terminology and definitions in literature","volume":"20","author":"Langedijk","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"5754","key":"10.1016\/j.tranon.2025.102365_bib0059","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1126\/science.1120781","article-title":"The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin","volume":"310","author":"Shaw","year":"2005","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.tranon.2025.102365_bib0060","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/bcpt.12898","article-title":"Patient- and cell type-specific heterogeneity of metformin response","volume":"122","author":"Asiedu","year":"2018","journal-title":"Basic. Clin. Pharmacol. Toxicol"},{"issue":"5","key":"10.1016\/j.tranon.2025.102365_bib0061","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/cncr.26439","article-title":"Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer","volume":"118","author":"Bayraktar","year":"2012","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.tranon.2025.102365_bib0062","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.2337\/dc14-0584","article-title":"Metformin does not affect cancer risk: a cohort study in the U.K. Clinical practice research datalink analyzed like an intention-to-treat trial","volume":"37","author":"Tsilidis","year":"2014","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.tranon.2025.102365_bib0063","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","article-title":"The influence of glucose-lowering therapies on cancer risk in type 2 diabetes","volume":"52","author":"Currie","year":"2009","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.tranon.2025.102365_bib0064","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1023\/A:1012128907225","article-title":"Chitosan and chitosan\/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines","volume":"14","author":"Calvo","year":"1997","journal-title":"Pharm. Res"},{"key":"10.1016\/j.tranon.2025.102365_bib0065","article-title":"Nano-mediated PDT as a multifunctional immunomodulatory agent in the intricate milieu of Melanoma","author":"Ahmed Sebak","year":"2024","journal-title":"Adv. Therap."},{"issue":"9","key":"10.1016\/j.tranon.2025.102365_bib0066","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1038\/nprot.2007.319","article-title":"Changing medium and passaging cell lines","volume":"2","author":"Masters","year":"2007","journal-title":"Nat. Protoc"},{"key":"10.1016\/j.tranon.2025.102365_bib0067","article-title":"Multitarget, multiagent PLGA nanoparticles for simultaneous tumor eradication and TME remodeling in a melanoma mouse model","author":"Ramzy","year":"2023","journal-title":"Drug. Deliv. Transl. Res"},{"issue":"5","key":"10.1016\/j.tranon.2025.102365_bib0068","doi-asserted-by":"crossref","DOI":"10.1117\/1.3494561","article-title":"How tissue optics affect dosimetry of photodynamic therapy","volume":"15","author":"Jacques","year":"2010","journal-title":"J. Biomed. Opt"},{"issue":"4","key":"10.1016\/j.tranon.2025.102365_bib0069","doi-asserted-by":"crossref","DOI":"10.1117\/1.3475953","article-title":"Thermal effects of white light illumination during microsurgery: clinical pilot study on the application safety of surgical microscopes","volume":"15","author":"Hibst","year":"2010","journal-title":"J. Biomed. Opt"},{"key":"10.1016\/j.tranon.2025.102365_bib0070","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pdpdt.2017.01.186","article-title":"Liposomal delivery of ferrous chlorophyllin: a novel third generation photosensitizer for in vitro PDT of melanoma","volume":"18","author":"Gomaa","year":"2017","journal-title":"Photodiagnosis. Photodyn. Ther"},{"issue":"3\u20134","key":"10.1016\/j.tranon.2025.102365_bib0071","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/08977194.2016.1200571","article-title":"Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor progression","volume":"34","author":"Youness","year":"2016","journal-title":"Growth. Factors"},{"key":"10.1016\/j.tranon.2025.102365_bib0072","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.saa.2017.01.040","article-title":"Colorimetric detection of endogenous hydrogen sulfide production in living cells","volume":"177","author":"Ahn","year":"2017","journal-title":"Spectrochim. Acta. A. Mol. Biomol. Spectrosc"},{"issue":"4","key":"10.1016\/j.tranon.2025.102365_bib0073","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.3892\/ol.2016.4914","article-title":"MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-myc","volume":"12","author":"Youness","year":"2016","journal-title":"Oncol. Lett"},{"key":"10.1016\/j.tranon.2025.102365_bib0074","doi-asserted-by":"crossref","first-page":"S1357","DOI":"10.1016\/j.annonc.2021.08.2036","article-title":"40P MALAT-1\/miR-30a-5p competing endogenous (ceRNA) network releases the brakes of immune surveillance in breast cancer through its quadruple targets: PD-L1, MIF, IL-10 and TNF-\u03b1","volume":"32","author":"Ramzy","year":"2021","journal-title":"Annal. Oncol."},{"key":"10.1016\/j.tranon.2025.102365_bib0075","first-page":"11","article-title":"Resistance to PD-L1\/PD-1 Blockade Immunotherapy. A tumor-intrinsic or tumor-extrinsic phenomenon?","author":"Chocarro de Erauso","year":"2020","journal-title":"Front. Pharmacol"},{"key":"10.1016\/j.tranon.2025.102365_bib0076","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1200\/EDBK_240837","article-title":"Mechanisms of resistance to Immune checkpoint blockade: why does checkpoint inhibitor immunotherapy not work for all patients?","volume":"39","author":"Fares","year":"2019","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"5","key":"10.1016\/j.tranon.2025.102365_bib0077","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/1389202916666150707155851","article-title":"Small and long non-coding RNAs: novel targets in perspective cancer therapy","volume":"16","author":"Han Li","year":"2015","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.tranon.2025.102365_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.113978","article-title":"Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 \/STAT3 \/ PD-L1 signaling pathways","volume":"274","author":"Deng","year":"2021","journal-title":"J. Ethnopharmacol"},{"issue":"5","key":"10.1016\/j.tranon.2025.102365_bib0079","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4155\/tde-2017-0101","article-title":"The effect of adjuvant therapy with TNF-alpha on animal model of triple-negative breast cancer","volume":"9","author":"Greish","year":"2018","journal-title":"Ther. Deliv."},{"issue":"9","key":"10.1016\/j.tranon.2025.102365_bib0080","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s41419-020-02992-y","article-title":"Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer","volume":"11","author":"Charan","year":"2020","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.tranon.2025.102365_bib0081","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4081\/oncol.2021.497","article-title":"Immunotherapy using PD-1\/PDL-1 inhibitors in metastatic triple-negative breast cancer: a systematic review","volume":"15","author":"Tavares","year":"2021","journal-title":"Oncol. Rev"},{"key":"10.1016\/j.tranon.2025.102365_bib0082","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000493962","article-title":"Long non-coding MALAT1 functions as a competing endogenous RNA to regulate vimentin expression by sponging miR-30a-5p in hepatocellular carcinoma","volume":"50","author":"Pan","year":"2018","journal-title":"Cellul. Physiol. Biochem"},{"issue":"2","key":"10.1016\/j.tranon.2025.102365_bib0083","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejpb.2011.08.004","article-title":"Expert opinion: responsive polymer nanoparticles in cancer therapy","volume":"80","author":"Liechty","year":"2012","journal-title":"Eur. J. Pharm. Biopharm"},{"issue":"17","key":"10.1016\/j.tranon.2025.102365_bib0084","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s00018-009-0053-z","article-title":"Nanocarriers' entry into the cell: relevance to drug delivery","volume":"66","author":"Hillaireau","year":"2009","journal-title":"Cell. Mol. Life. Sci"},{"issue":"8","key":"10.1016\/j.tranon.2025.102365_bib0085","first-page":"11","article-title":"The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application","author":"Wu","year":"2021","journal-title":"J. Pers. Med"},{"key":"10.1016\/j.tranon.2025.102365_bib0086","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2147\/IJN.S247893","article-title":"Co-delivery of curcumin and cisplatin to enhance cytotoxicity of cisplatin using lipid-chitosan hybrid nanoparticles","volume":"15","author":"Khan","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.tranon.2025.102365_bib0087","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-5173(96)04801-6","article-title":"Interactions between liposomes and chitosan II: effect of selected parameters on aggregation and leakage","volume":"146","author":"Henriksen","year":"1997","journal-title":"Int. J. Pharm"},{"key":"10.1016\/j.tranon.2025.102365_bib0088","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ijbiomac.2019.07.168","article-title":"Cellular uptake and transport characteristics of chitosan modified nanoparticles in Caco-2 cell monolayers","volume":"138","author":"Dou","year":"2019","journal-title":"Int. J. Biol. Macromol"},{"key":"10.1016\/j.tranon.2025.102365_bib0089","doi-asserted-by":"crossref","DOI":"10.22159\/ijap.2018v10i5.27568","article-title":"Limitations of pegylated nanocarriers: unfavourable physicochemical properties, biodistribution patterns and cellular and subcellular fates","author":"Sebak","year":"2018","journal-title":"Int. J. Appl. Pharmac."},{"key":"10.1016\/j.tranon.2025.102365_bib0090","doi-asserted-by":"crossref","first-page":"8845","DOI":"10.2147\/IJN.S273713","article-title":"Distinct proteins in protein corona of nanoparticles represent a promising venue for endogenous targeting - part I: in vitro release and intracellular uptake perspective","volume":"15","author":"Sebak","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.tranon.2025.102365_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110075","article-title":"Autophagy inhibition in breast cancer cells induces ROS-mediated MIF expression and M1 macrophage polarization","volume":"86","author":"Cotzomi-Ortega","year":"2021","journal-title":"Cell Signal"},{"issue":"5","key":"10.1016\/j.tranon.2025.102365_bib0092","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051253","article-title":"Triple negative breast cancer: updates on classification and treatment in 2021","volume":"14","author":"Bou Zerdan","year":"2022","journal-title":"Cancer. (Basel)"},{"issue":"1","key":"10.1016\/j.tranon.2025.102365_bib0093","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1038\/s41598-022-07027-4","article-title":"BCL2A1 regulates Canady Helios Cold plasma-induced cell death in triple-negative breast cancer","volume":"12","author":"Murthy","year":"2022","journal-title":"Sci. Rep"},{"issue":"1","key":"10.1016\/j.tranon.2025.102365_bib0094","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12967-022-03319-5","article-title":"Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancers","volume":"20","author":"Toney","year":"2022","journal-title":"J. Transl. Med"},{"issue":"1","key":"10.1016\/j.tranon.2025.102365_bib0095","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/bcr1648","article-title":"Oestrogen receptor negative breast cancers exhibit high cytokine content","volume":"9","author":"Chavey","year":"2007","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.tranon.2025.102365_bib0096","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-011-1855-x","article-title":"Role of interleukin-10 in breast cancer","volume":"133","author":"Hamidullah","year":"2012","journal-title":"Breast Cancer Res. Treat"},{"issue":"10","key":"10.1016\/j.tranon.2025.102365_bib0097","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/j.jprot.2011.11.033","article-title":"Stat1 and CD74 overexpression is co-dependent and linked to increased invasion and lymph node metastasis in triple-negative breast cancer","volume":"75","author":"Greenwood","year":"2012","journal-title":"J. Proteomics"},{"issue":"2","key":"10.1016\/j.tranon.2025.102365_bib0098","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/0971-5851.180136","article-title":"The correlation between Ki-67 with other prognostic factors in breast cancer: a study in Iranian patients","volume":"37","author":"Madani","year":"2016","journal-title":"Ind. J. Med. Paediatr. Oncol."},{"issue":"11","key":"10.1016\/j.tranon.2025.102365_bib0099","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1745-7254.2008.00889.x","article-title":"Tumor necrosis factor and cancer, buddies or foes?","volume":"29","author":"Wang","year":"2008","journal-title":"Acta. Pharmacol. Sin"},{"key":"10.1016\/j.tranon.2025.102365_bib0100","unstructured":"Gonz\u00e1lez-Garza, M., D. Cruz-Vega, and C. Bernal, IL10 as cancer biomarker. 2020."},{"issue":"7","key":"10.1016\/j.tranon.2025.102365_bib0101","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1172\/JCI97944","article-title":"Phospholipid signaling in innate immune cells","volume":"128","author":"O'Donnell","year":"2018","journal-title":"J. Clin. Invest"},{"issue":"38","key":"10.1016\/j.tranon.2025.102365_bib0102","doi-asserted-by":"crossref","first-page":"9952","DOI":"10.1016\/j.biomaterials.2013.09.012","article-title":"Macrophage polarization following chitosan implantation","volume":"34","author":"Vasconcelos","year":"2013","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.tranon.2025.102365_bib0103","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.actbio.2013.10.035","article-title":"Impact of 3-D printed PLA- and chitosan-based scaffolds on human monocyte\/macrophage responses: unraveling the effect of 3-D structures on inflammation","volume":"10","author":"Almeida","year":"2014","journal-title":"Acta. Biomater"},{"key":"10.1016\/j.tranon.2025.102365_bib0104","series-title":"Nanomaterial properties: size and shape dependencies","author":"Guisbiers","year":"2012"},{"issue":"12","key":"10.1016\/j.tranon.2025.102365_bib0105","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1039\/c3cs60064e","article-title":"Cytokines as biomarkers of nanoparticle immunotoxicity","volume":"42","author":"Elsabahy","year":"2013","journal-title":"Chem. Soc. Rev"},{"key":"10.1016\/j.tranon.2025.102365_bib0106","first-page":"4","article-title":"Chitosan immunomodulatory properties: perspectives on the impact of structural properties and dosage","author":"Fong","year":"2017","journal-title":"Fut. Sci. Open Access"},{"issue":"1","key":"10.1016\/j.tranon.2025.102365_bib0107","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.colsurfa.2011.09.047","article-title":"Studies on aggregation behaviour of silver nanoparticles in aqueous matrices: effect of surface functionalization and matrix composition","volume":"390","author":"Prathna","year":"2011","journal-title":"Colloid. Surfac. A"},{"issue":"5","key":"10.1016\/j.tranon.2025.102365_bib0108","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrc1071","article-title":"Photodynamic therapy for cancer","volume":"3","author":"Dolmans","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.tranon.2025.102365_bib0109","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s10620-011-1957-7","article-title":"Photodynamic therapy for unresectable cholangiocarcinoma","volume":"57","author":"Tomizawa","year":"2012","journal-title":"Dig. Dis. Sci"},{"key":"10.1016\/j.tranon.2025.102365_bib0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114344","article-title":"Light-triggered photodynamic nanomedicines for overcoming localized therapeutic efficacy in cancer treatment","author":"Choi","year":"2022","journal-title":"Adv. Drug. Deliv. Rev"},{"issue":"5","key":"10.1016\/j.tranon.2025.102365_bib0111","first-page":"308","article-title":"Photodynamic therapy in combination with chemotherapy, targeted, and immunotherapy As a successful therapeutic approach for advanced gastric adenocarcinoma: a case report and literature review","volume":"40","author":"Ma","year":"2022","journal-title":"Photobiomodul. Photomed. Laser. Surg"},{"key":"10.1016\/j.tranon.2025.102365_bib0112","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.canlet.2017.04.034","article-title":"miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect","volume":"400","author":"Li","year":"2017","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.tranon.2025.102365_bib0113","first-page":"60","article-title":"Circular RNAs: new layer of complexity evading breast cancer heterogeneity","volume":"8","author":"Dawoud","year":"2023","journal-title":"Noncod. RNA Res"},{"issue":"8","key":"10.1016\/j.tranon.2025.102365_bib0114","doi-asserted-by":"crossref","first-page":"13893","DOI":"10.1002\/jcb.28662","article-title":"lncRNA TINCR participates in ALA-PDT-induced apoptosis and autophagy in cutaneous squamous cell carcinoma","volume":"120","author":"Zhou","year":"2019","journal-title":"J. Cell Biochem"},{"key":"10.1016\/j.tranon.2025.102365_bib0115","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ejmech.2017.10.011","article-title":"The role of microRNAs in photodynamic therapy of cancer","volume":"142","author":"El-Daly","year":"2017","journal-title":"Eur. J. Med. Chem"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325000968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325000968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:34:59Z","timestamp":1762562099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325000968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":115,"alternative-id":["S1936523325000968"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102365","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-vitro immune-modulation of triple-negative breast cancer through targeting miR-30a-5p\/MALAT1 axis using nano-PDT combinational approach","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}],"article-number":"102365"}}